Gland Pharma Ltd share price logo

Gland Pharma Share Price

(GLAND)

₹1554.851.54%

as on 04:01PM, 13 Mar 2025

bell
The current prices are delayed by 15 mins, login to check live prices.

Gland Pharma Performance

  • Day's Low

    Day's High

    ₹1,545.75
    Day's Price Range
    ₹1,595
  • 52 Week's Low

    52 Week's High

    ₹1,411.1
    52-Week Price Range
    ₹2,220.95
1 Month Return+ 5.15 %
3 Month Return-10.19 %
1 Year Return-13.14 %
Previous Close₹1,579.10
Open₹1,585.00
Volume1.41L
Upper Circuit-
Lower Circuit-
Market Cap₹25,617.15Cr

Gland Pharma Key Statistics

P/E Ratio

36.36

PEG Ratio

13.17

Market Cap

₹25,617.15 Cr

P/B Ratio

3.37

EPS

46.9

Dividend Yield

1.09

Sector

Pharmaceuticals

ROE

12.31

Gland Pharma Analyst Rating

based on 12 analysts

HOLD

41.67%

Buy

8.33%

Hold

50.00%

Sell

Based on 12 analysts offering long term price targets for Gland Pharma. An average target of ₹1690.58

Source: S&P Global Market Intelligence

Gland Pharma Share analysis

Gland Pharma price forecast by 12 analysts

Upside of8.73%

High

₹3120

Target

₹1690.58

Low

₹1162

Gland Pharma target price ₹1690.58, a slight upside of 8.73% compared to current price of ₹1554.85. According to 12 analysts rating.

Source: S&P Global Market Intelligence

Key events for Gland Pharma Ltd

  • Gland Pharma Faces FDA Observations at Vizag Facility - 25 Feb, 2025

    Gland Pharma's Visakhapatnam facility received three procedural observations from the FDA following a pre-approval inspection. The company plans to submit corrective actions promptly.
  • Gland Pharma Shares Decline Amid Market Capitalization Update - 24 Feb, 2025

    Gland Pharma Limited's shares traded at Rs. 1,509.35, down 0.98% from the previous close. The company has a market capitalization of Rs. 24,866.80 crores, with 53% revenue exposure to the U.S. as of 9MFY25.
  • Gland Pharma Target Price and Turnaround Potential - 19 Feb, 2025

    Gland Pharma is under consideration for a turnaround due to potential corporate actions. Currently trading at Rs 1499.55, with a target price of Rs 1,654.
  • Gland Pharma Attracts Major Private Equity Interest - 12 Feb, 2025

    Global private equity firms Blackstone, Brookfield, and Warburg Pincus are in talks to acquire a majority stake in Gland Pharma, valued at nearly $3 billion. The company reported a revenue of ₹1,384 crore for the December quarter, with a profit after tax of ₹204.7 crore, indicating strong financial performance.
  • Gland Pharma Target Price Adjusted to Rs 1840 - 05 Feb, 2025

    Motilal Oswal recommends buying Gland Pharma with a target price of Rs 1840, citing better-than-expected margins despite challenges in Cenexi operations and a reduced earnings estimate.
  • Gland Pharma Faces Revenue Decline and Share Drop - 04 Feb, 2025

    Gland Pharma's Q3 results show a 7% PAT rise but a 10% revenue decline, leading to a 5% drop in shares. Analysts downgrade targets amid ongoing challenges with the Cenexi acquisition and weak US market performance.
  • Gland Pharma Reports Mixed Q3 Results - 03 Feb, 2025

    Gland Pharma's Q3 results show a 7% increase in net profit to ₹205 crore, despite a 10% decline in revenue to ₹1,384 crore. The company cites lower expenses mitigating production issues at its French unit, Cenexi, and emphasizes strategic partnerships for future growth.

Insights on Gland Pharma Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 3 quarters, 143.76 Cr → 204.69 Cr (in ₹), with an average increase of 16.1% per quarter

  • imgPOSITIVE IMPACT

    FII Holding Up

    img

    Foreign Institutions have increased holdings from 4.47% to 5.04% in Dec 2024 quarter

  • imgPOSITIVE IMPACT

    Retail Holding Up

    img

    Retail Investor have increased holdings from 8.32% to 8.33% in Dec 2024 quarter

  • imgNO EFFECT

    Promoter Holding Unchanged

    img

    Promoters holdings remained unchanged at 51.83% of holdings in Dec 2024 quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Torrent Pharmaceuticals Ltd has given 112.9% return, outperforming this stock by 165.4%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Divis Laboratories Ltd has given 61.3% return, outperforming this stock by 74.4%

  • imgNEGATIVE IMPACT

    Revenue Fall

    img

    Revenue is down for the last 2 quarters, 1.46K Cr → 1.44K Cr (in ₹), with an average decrease of 1.6% per quarter

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 3 years, GLAND stock has moved down by -52.5%

  • imgNEGATIVE IMPACT

    MF Holding Down

    img

    Mutual Funds have decreased holdings from 32.83% to 32.37% in Dec 2024 quarter

Gland Pharma Financials

Value in ₹ crore
DetailsQ'4 23Q'1 24Q'2 24Q'3 24Q'4 24
Revenue₹1,545.16Cr (-)₹1,537.45Cr (↓0.50%)₹1,401.71Cr (↓8.83%)₹1,405.83Cr (↑0.29%)₹1,384.05Cr (↓1.55%)
Net Income₹191.86Cr (-)₹192.42Cr (↑0.29%)₹143.76Cr (↓25.29%)₹163.53Cr (↑13.75%)₹204.69Cr (↑25.17%)
Net Profit Margin12.42% (-)12.52% (↑0.81%)10.26% (↓18.05%)11.63% (↑13.35%)14.79% (↑27.17%)
Value in ₹ crore
Details2021202220232024
Total Assets₹6,502.07Cr (-)₹7,841.79Cr (↑20.60%)₹8,795.89Cr (↑12.17%)₹9,549.38Cr (↑8.57%)
Total Liabilities₹598.78Cr (-)₹683.56Cr (↑14.16%)₹842.59Cr (↑23.26%)₹554.09Cr (↓34.24%)
Value in ₹ crore
Details20202021202220232024
Operating Cash Flow₹700.94Cr (-)₹604.93Cr (↓13.70%)₹791.29Cr (↑30.81%)₹367.89Cr (↓53.51%)₹1,135.97Cr (↑208.78%)

Index Inclusions

BSE Mid-Cap

₹39,062.82

-0.77 (-301.77%)

Nifty 500

₹20,176.05

-0.44 (-88.3%)

S&P BSE 250 LargeMidCap

₹9,501.66

-0.4 (-37.95%)

BSE Healthcare

₹39,295.43

-0.2 (-80.11%)

Nifty MNC

₹25,286.80

-0.47 (-119.9%)

Nifty Midcap 150

₹17,902.00

-0.62 (-112.25%)

Nifty LargeMidcap 250

₹13,976.60

-0.48 (-68.1%)

NIFTY PHARMA

₹20,386.85

-0.18 (-37.15%)

BSE 500

₹31,785.90

-0.42 (-133.72%)

S&P BSE 150 MidCap

₹13,532.88

-0.66 (-89.72%)

Nifty MidSmallcap 400

₹16,532.60

-0.65 (-107.65%)

S&P BSE 400 MidSmallCap

₹10,111.91

-0.65 (-66.01%)

S&P BSE AllCap

₹10,471.31

0.68 (71.07%)

Gland Pharma Shareholding Pattern

InvestorsHoldings %FY Quarter3M change
Promoter Holdings
51.83%
0.00
Foreign Institutions
5.04%
12.69
Mutual Funds
32.37%
-1.41
Retail Investors
8.33%
0.10
Others
2.43%
-4.50

Gland Pharma Key Indicators

Details2021202220232024
Earning Per Share (₹)60.9473.7547.4246.9
Details20202021202220232024
Return On Equity %23.7520.8818.5610.2712.31
Details2021202220232024
Return On Assets %15.3315.458.888.09
Details2021202220232024
Book Value Per Share (₹)360.86435.64483.23529.65

Gland Pharma Valuation

Gland Pharma in the last 5 years

  • Overview

  • Trends

Lowest (18.84x)

May 22, 2023

Today (36.36x)

March 13, 2025

Industry (50.82x)

March 13, 2025

Highest (67.14x)

August 12, 2021

LowHigh

Gland Pharma Earnings and Dividends

  • Gland Pharma Ltd Earnings Results

    Gland Pharma Ltd’s net profit jumped 6.69% since last year same period to ₹204.69Cr in the Q3 2024-2025. On a quarterly growth basis, Gland Pharma Ltd has generated 25.17% jump in its net profits since last 3-months.

    Read More about Earnings Results
  • Gland Pharma Ltd Dividends May,2024

    In the quarter ending March 2024, Gland Pharma Ltd has declared dividend of ₹20 - translating a dividend yield of 1.29%.

    Read More about Dividends

Gland Pharma Technicals Summary

Bearish

Neutral

Bullish

Bearish

Gland Pharma Ltd is currently in a Bearish trading position according to technical analysis indicators.

Gland Pharma Peer Comparison

Company
Analyst ViewMarket Cap5 Year CAGRDebt to Asset RatioNet ProfitYearly Revenue
HOLD₹25,617.15 Cr-2.91%0.50₹772 Cr₹5,664 Cr
HOLD₹1,49,205.29 Cr39.42%0.50₹1,600 Cr₹7,845 Cr
BUY₹1,03,425.97 Cr42.36%0.67₹1,656 Cr₹10,727 Cr
BUY₹38,785.38 Cr4.09%0.58₹1,297 Cr₹14,755 Cr
BUY₹1,18,065.23 Cr53.76%0.50₹4,155 Cr₹25,774 Cr

About Gland Pharma

Gland Pharma Ltd is an Indian pharmaceutical company that was founded in 1978. The company is headquartered in Hyderabad and specializes in the development and manufacture of injectable drugs and active pharmaceutical ingredients (APIs). It is one of the largest independent companies in the world that provides high-quality, cost-effective injectable products.

Gland Pharma's operations include the development, manufacture, and marketing of a wide range of injectable drugs and active pharmaceutical ingredients. The company's product portfolio includes antibiotics, anti-emetics, anti-diabetics, anti-epileptics, and other therapeutic categories. Its top products include cephalosporins, penicillins, and other injectable antibiotics.

Gland Pharma is well known for its popular brands, such as Cephalosporin, Penicillin, and Amikacin. These brands have been widely used in hospitals and clinics across India, as well as in other countries. In addition, the company has developed and launched a wide range of generic and branded injectables, including Cefazolin, Cefuroxime, and Amikacin.

Share Price: ₹1554.85 per share as on 13 Mar, 2025 04:01 PM
Market Capitalisation: ₹25,617.15Cr as of today
Revenue: ₹1,384.05Cr as on December 2024 (Q4 24)
Net Profit: ₹204.69Cr as on December 2024 (Q4 24)
Listing date: 20 Nov, 2020
Chairperson Name: Yiu Kwan Stanley Lau
OrganisationGland Pharma
Headquarters
IndustryPharmaceuticals
E-voting on sharesClick here to vote

FAQs on Gland Pharma Ltd

What is Gland Pharma Ltd price today?

Gland Pharma Ltd share price today stands at ₹1554.85, Open: ₹1585, Previous Close: ₹1579.1, High: ₹1595, Low: ₹1545.75, 52 Week High: ₹2220.95, 52 Week Low: ₹1411.1.

How to Buy Gland Pharma Ltd Share in India?

  • Get a PAN card
  • Open a Demat account
  • Open a Trading account
  • Link your Demat account to your Trading account
  • Fund your Trading account
  • Place an order to buy Gland Pharma Ltd shares

Is Gland Pharma Ltd listed on NSE?

Gland Pharma Ltd is listed on NSE

Is Gland Pharma Ltd listed on BSE?

Gland Pharma Ltd is listed on BSE

What are today's High and Low prices of Gland Pharma Ltd?

  • Today's highest price of Gland Pharma Ltd is ₹1595.
  • Today's lowest price of Gland Pharma Ltd is ₹1545.75.

What are today's traded volumes of Gland Pharma Ltd?

Today's traded volume of Gland Pharma Ltd(GLAND) is 1.41L.

What is today's market capitalisation of Gland Pharma Ltd?

Today's market capitalisation of Gland Pharma Ltd(GLAND) is ₹25617.15Cr.

What is the 52 Week High and Low Range of Gland Pharma Ltd?

Gland Pharma Ltd (GLAND)
Price
52 Week High
₹2220.95
52 Week Low
₹1411.1

How much percentage Gland Pharma Ltd is down from its 52 Week High?

Gland Pharma Ltd (GLAND) share price is ₹1554.85. It is down -29.99% from its 52 Week High price of ₹2220.95

How much percentage Gland Pharma Ltd is up from its 52 Week low?

Gland Pharma Ltd (GLAND) share price is ₹1554.85. It is up 10.19% from its 52 Week Low price of ₹1411.1

What are the historical returns of Gland Pharma Ltd?

Gland Pharma Ltd (GLAND)
Returns
1 Day Returns
-24.25%
1 Month Returns
5.15%
3 Month Returns
-10.19%
1 Year Returns
-13.14%

What is the PE ratio of Gland Pharma Ltd today?

PE Ratio of Gland Pharma Ltd is 36.36

PE ratio = Gland Pharma Ltd Market price per share / Gland Pharma Ltd Earnings per share